Public Profile

OPOCRIN GROUP

OPOCRIN GROUP, headquartered in Italy, is a prominent player in the pharmaceutical and biotechnology industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 1946, the company has established a strong presence in Europe and beyond, with significant operations across various international markets. Renowned for its commitment to innovation and quality, OPOCRIN GROUP offers a diverse range of products, including generic medicines and niche therapeutic solutions. The company’s unique approach to research and development, combined with state-of-the-art manufacturing facilities, positions it as a leader in the sector. With a rich history of milestones, OPOCRIN GROUP continues to achieve notable success, reinforcing its reputation as a trusted partner in the pharmaceutical landscape.

DitchCarbon Score

How does OPOCRIN GROUP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

OPOCRIN GROUP's score of 23 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.

49%

Let us know if this data was useful to you

OPOCRIN GROUP's reported carbon emissions

OPOCRIN GROUP, headquartered in Italy, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. As the industry increasingly focuses on sustainability, OPOCRIN GROUP may need to establish clear climate commitments and reduction initiatives to align with global standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. OPOCRIN GROUP's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for OPOCRIN GROUP is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

OPOCRIN GROUP is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers